H6H
VIR icon

Hightower 6M Holding’s Vir Biotechnology VIR Stock Holding History

Hightower 6M Holding’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$248K Buy
+12,888
New +$328K 0.02% 191

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Hightower 6M Holding's VIR Position: Q3 2022 in Review

Hightower 6M Holding opened a new position in Vir Biotechnology (VIR) in Q3 2022: 12,888 shares worth $248K. The stake represents 0.02% of the portfolio and ranks #191 among its holdings.

220 funds tracked by Wall St. Rank hold VIR as of Q3 2022.

  • Hightower 6M Holding held 12,888 shares of Vir Biotechnology worth $248K as of Q3 2022.
  • Vir Biotechnology was a new Hightower 6M Holding position in Q3 2022.
  • Vir Biotechnology made up 0.02% of Hightower 6M Holding's portfolio in Q3 2022, its #191 holding.
  • 220 funds tracked by Wall St. Rank held Vir Biotechnology as of Q3 2022.

Based on Hightower 6M Holding's 13F filing for Q3 2022, filed 25 Oct 2022.